The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Acute Hepatic Porphyria Drug Market Research Report 2025

Global Acute Hepatic Porphyria Drug Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1987652

No of Pages : 61

Ask Your Query
Synopsis
Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria.
The global Acute Hepatic Porphyria Drug market was valued at US$ 4 million in 2023 and is anticipated to reach US$ 5 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Acute Hepatic Porphyria Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Hepatic Porphyria Drug.
Report Scope
The Acute Hepatic Porphyria Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Hepatic Porphyria Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Hepatic Porphyria Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Recordati Rare Diseases
Segment by Type
350 Mg
313 Mg
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Hepatic Porphyria Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 350 Mg
1.2.3 313 Mg
1.3 Market by Application
1.3.1 Global Acute Hepatic Porphyria Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Hepatic Porphyria Drug Market Perspective (2019-2030)
2.2 Acute Hepatic Porphyria Drug Growth Trends by Region
2.2.1 Global Acute Hepatic Porphyria Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Hepatic Porphyria Drug Historic Market Size by Region (2019-2024)
2.2.3 Acute Hepatic Porphyria Drug Forecasted Market Size by Region (2025-2030)
2.3 Acute Hepatic Porphyria Drug Market Dynamics
2.3.1 Acute Hepatic Porphyria Drug Industry Trends
2.3.2 Acute Hepatic Porphyria Drug Market Drivers
2.3.3 Acute Hepatic Porphyria Drug Market Challenges
2.3.4 Acute Hepatic Porphyria Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Hepatic Porphyria Drug Players by Revenue
3.1.1 Global Top Acute Hepatic Porphyria Drug Players by Revenue (2019-2024)
3.1.2 Global Acute Hepatic Porphyria Drug Revenue Market Share by Players (2019-2024)
3.2 Global Acute Hepatic Porphyria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Hepatic Porphyria Drug Revenue
3.4 Global Acute Hepatic Porphyria Drug Market Concentration Ratio
3.4.1 Global Acute Hepatic Porphyria Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Hepatic Porphyria Drug Revenue in 2023
3.5 Acute Hepatic Porphyria Drug Key Players Head office and Area Served
3.6 Key Players Acute Hepatic Porphyria Drug Product Solution and Service
3.7 Date of Enter into Acute Hepatic Porphyria Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Hepatic Porphyria Drug Breakdown Data by Type
4.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Type (2019-2024)
4.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2025-2030)
5 Acute Hepatic Porphyria Drug Breakdown Data by Application
5.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Application (2019-2024)
5.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Hepatic Porphyria Drug Market Size (2019-2030)
6.2 North America Acute Hepatic Porphyria Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acute Hepatic Porphyria Drug Market Size by Country (2019-2024)
6.4 North America Acute Hepatic Porphyria Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Hepatic Porphyria Drug Market Size (2019-2030)
7.2 Europe Acute Hepatic Porphyria Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acute Hepatic Porphyria Drug Market Size by Country (2019-2024)
7.4 Europe Acute Hepatic Porphyria Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Hepatic Porphyria Drug Market Size (2019-2030)
8.2 Asia-Pacific Acute Hepatic Porphyria Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Hepatic Porphyria Drug Market Size (2019-2030)
9.2 Latin America Acute Hepatic Porphyria Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acute Hepatic Porphyria Drug Market Size by Country (2019-2024)
9.4 Latin America Acute Hepatic Porphyria Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Hepatic Porphyria Drug Market Size (2019-2030)
10.2 Middle East & Africa Acute Hepatic Porphyria Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Acute Hepatic Porphyria Drug Business (2019-2024)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Recordati Rare Diseases
11.2.1 Recordati Rare Diseases Company Detail
11.2.2 Recordati Rare Diseases Business Overview
11.2.3 Recordati Rare Diseases Acute Hepatic Porphyria Drug Introduction
11.2.4 Recordati Rare Diseases Revenue in Acute Hepatic Porphyria Drug Business (2019-2024)
11.2.5 Recordati Rare Diseases Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 350 Mg
Table 3. Key Players of 313 Mg
Table 4. Global Acute Hepatic Porphyria Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Acute Hepatic Porphyria Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Acute Hepatic Porphyria Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Acute Hepatic Porphyria Drug Market Share by Region (2019-2024)
Table 8. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Acute Hepatic Porphyria Drug Market Share by Region (2025-2030)
Table 10. Acute Hepatic Porphyria Drug Market Trends
Table 11. Acute Hepatic Porphyria Drug Market Drivers
Table 12. Acute Hepatic Porphyria Drug Market Challenges
Table 13. Acute Hepatic Porphyria Drug Market Restraints
Table 14. Global Acute Hepatic Porphyria Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Acute Hepatic Porphyria Drug Market Share by Players (2019-2024)
Table 16. Global Top Acute Hepatic Porphyria Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2023)
Table 17. Ranking of Global Top Acute Hepatic Porphyria Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Acute Hepatic Porphyria Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Hepatic Porphyria Drug Product Solution and Service
Table 21. Date of Enter into Acute Hepatic Porphyria Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Hepatic Porphyria Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Acute Hepatic Porphyria Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Acute Hepatic Porphyria Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Acute Hepatic Porphyria Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Acute Hepatic Porphyria Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Acute Hepatic Porphyria Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Acute Hepatic Porphyria Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Alnylam Pharmaceuticals Company Detail
Table 47. Alnylam Pharmaceuticals Business Overview
Table 48. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product
Table 49. Alnylam Pharmaceuticals Revenue in Acute Hepatic Porphyria Drug Business (2019-2024) & (US$ Million)
Table 50. Alnylam Pharmaceuticals Recent Development
Table 51. Recordati Rare Diseases Company Detail
Table 52. Recordati Rare Diseases Business Overview
Table 53. Recordati Rare Diseases Acute Hepatic Porphyria Drug Product
Table 54. Recordati Rare Diseases Revenue in Acute Hepatic Porphyria Drug Business (2019-2024) & (US$ Million)
Table 55. Recordati Rare Diseases Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Hepatic Porphyria Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Acute Hepatic Porphyria Drug Market Share by Type: 2023 VS 2030
Figure 3. 350 Mg Features
Figure 4. 313 Mg Features
Figure 5. Global Acute Hepatic Porphyria Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Acute Hepatic Porphyria Drug Market Share by Application: 2023 VS 2030
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Hepatic Porphyria Drug Report Years Considered
Figure 12. Global Acute Hepatic Porphyria Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Acute Hepatic Porphyria Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Acute Hepatic Porphyria Drug Market Share by Region: 2023 VS 2030
Figure 15. Global Acute Hepatic Porphyria Drug Market Share by Players in 2023
Figure 16. Global Top Acute Hepatic Porphyria Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Acute Hepatic Porphyria Drug Revenue in 2023
Figure 18. North America Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Acute Hepatic Porphyria Drug Market Share by Country (2019-2030)
Figure 20. United States Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Acute Hepatic Porphyria Drug Market Share by Country (2019-2030)
Figure 24. Germany Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Region (2019-2030)
Figure 32. China Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Acute Hepatic Porphyria Drug Market Share by Country (2019-2030)
Figure 40. Mexico Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Acute Hepatic Porphyria Drug Market Share by Country (2019-2030)
Figure 44. Turkey Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Acute Hepatic Porphyria Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Alnylam Pharmaceuticals Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2019-2024)
Figure 47. Recordati Rare Diseases Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock